Harbin Jixianglong Biotech recalls

Harbin Jixianglong Biotech appears in 2 official U.S. recall notices indexed by RecallRadar, most recently on 2026-03-11.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01
  FDA Drug · Class II · 2026-03-11 · Harbin Jixianglong Biotech
• Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01
  FDA Drug · Class II · 2026-03-11 · Harbin Jixianglong Biotech